GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sina Darou Laboratories (XTEH:DSIN1) » Definitions » Beta

Sina Darou Laboratories (XTEH:DSIN1) Beta : N/A (As of Sep. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Sina Darou Laboratories Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-09-25), Sina Darou Laboratories's Beta is Not available.


Sina Darou Laboratories Beta Historical Data

The historical data trend for Sina Darou Laboratories's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sina Darou Laboratories Beta Chart

Sina Darou Laboratories Annual Data
Trend
Beta

Sina Darou Laboratories Quarterly Data
Beta

Competitive Comparison of Sina Darou Laboratories's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Sina Darou Laboratories's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sina Darou Laboratories's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sina Darou Laboratories's Beta distribution charts can be found below:

* The bar in red indicates where Sina Darou Laboratories's Beta falls into.



Sina Darou Laboratories Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Sina Darou Laboratories  (XTEH:DSIN1) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Sina Darou Laboratories Beta Related Terms

Thank you for viewing the detailed overview of Sina Darou Laboratories's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Sina Darou Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Kilometer 15 of special road to Karaj, Shahid Anhomesh Street, 52nd Boulevard, Tehran, IRN, 1388167311
Sina Darou Laboratories is engaged in the manufacturing of pharmaceutical products in Iran. The company's product offerings include sterile eye ointments, nasal sprays, sterile eye drops, inhalers, sterile ear drops, injections, respiratory sprays, vaginal creams, ampoules, and ophthalmic solutions, among others. It is also engaged in exporting its products to neighboring countries.

Sina Darou Laboratories Headlines

No Headlines